You just read:

NW Bio Provides Update About Phase 3 Trial Of DCVax®-L for Newly Diagnosed Glioblastoma Multiforme Brain Cancer

News provided by

Northwest Biotherapeutics

08 Dec, 2016, 14:04 ET